- ICH GCP
- Rejestr badań klinicznych w USA
- Badanie kliniczne NCT00346554
To Study the Prevalence of Insomnia in Geriatric COPD Patients Who Are Enrolled in a Pulmonary Rehabilitation Program.
Przegląd badań
Status
Warunki
Szczegółowy opis
Hackensack University Medical Center Institutional Review Board
PROTOCOL: To study the prevalence of insomnia in geriatric COPD patients who are enrolled in a pulmonary rehabilitation program.
I. OBJECTIVES OF THE STUDY
RATIONALE:
The goal for geriatric patients with COPD and enrolled in pulmonary rehabilitation programs is to improve the quality of life. COPD is known to be worse at night as are other respiratory problems such as CHF. Saturation is known to get worse nocturnally as well. Furthermore, these COPD rehabilitation patients tend to be older, and increasing age is associated with an increase in the incidence of sleep disorders. We suspect that there is an increase in the incidence of difficulty initiating and maintaining sleep in COPD patients. A preliminary study was done by the chest medicine specialist in our group, but the results were not comparable to national statistics and were inconclusive. We plan to further evaluate the geriatric COPD patients in pulmonary rehabilitation with initial screening questionnaire and diagnostic screening questionnaires (MMSE, Beck's Anxiety Inventory, Beck's Depression Inventory, and Epworth Sleepiness Scale).
GOALS:
- To determine the incidence and prevalence of insomnia (difficulty initiating sleep (DIS), and/or difficulty maintaining sleep (DMS) in the geriatric population with COPD in a rehabilitation program.
- To determine how many of these patients suffer from anxiety and/or depression.
HYPOTHESIS:
The incidence of insomnia (DIS and/or DMS), along with anxiety/depression is more prevalent in geriatric patients with COPD.
II. BACKGROUND MATERIAL According to the American Academy of Sleep Medicine (AASM), over a six-month period, 20 million Americans complained of insomnia.
COPD patients tend to have decreased total sleep time (32% reported total sleep time less than 6 hours). According to previous studies conducted, the following was reported:
- 15% reported to have insomnia;
- 28% reported poor quality sleep due to anxiety and/or depression;
- 12% reported > 3 awakenings due to unknown origin.
RESULTS OF PILOT:
In the pilot study, a preliminary general (initial) questionnaire was used and will continue to be used as a tool for general screening purposes. And diagnostic questionnaires will be used, which are the following:
- Beck's Anxiety Inventory
- Beck's Depression Inventory
- Epworth Sleepiness Scale
- MMSE
III. DRUG INFORMATION
No drugs are used in this study protocol.
IV. INCLUSIONARY CRITERIA
Geriatric patients with COPD enrolled in the rehabilitation program with FEV1<60%.
V. EXCLUSIONARY CRITERIA
Geriatric patients without a clear diagnosis of COPD. Geriatric patients whose FEV1>60%. Geriatric patients who are unable to answer the questionnaire.
VI. RECRUITMENT PROCEDURES
Geriatric patients in the HUMC pulmonary rehabilitation program who consent to answer the questionnaire and with an FEV1<60% will be enrolled.
VII. METHODOLOGY
Screening: Charts will be reviewed to see which patients meet the criteria of the study.
Informed Consent: If the patient is eligible for diagnostic screening, then an informed consent will be taken.
Randomization: None
Baseline evaluation: Geriatric patients will be asked the questions in the questionnaire.
Follow-up: If insomnia is found, patient will be referred for further treatment.
Withdrawal and Termination: The patient is unable to complete the questionnaire.
VIII. DISCOMFORT AND RISKS
No direct risks to the patient. Failure to follow-up in the clinic if indicated could be problematic.
IX. BENEFITS
Recognition and treatment of sleep problems in this group of patients will add to our understanding of problems in COPD.
X. CRITERIA FOR EVALUATING RESPONSE
No response anticipated from the study protocol.
XI. CONFIDENTIALITY
All results will be kept confidential. Data will only be used by the investigators. Data can be reviewed by the IRB at any time. HIPPA forms will be used for the patient's permission.
XII. PRIMARY INVESTIGATOR
Hormoz Ashtyani, M.D.
CO PRIMARY INVESTIGATOR
Susan Zafarlotfi Ph.D
GERIATRIC MEDICINE SPECIALIST
Knight R. Steel, M.D.
RESEARCH COORDINATOR
Mohammad Quadri, M.D. (MBA) RPSGT
Typ studiów
Zapisy (Rzeczywisty)
Kontakty i lokalizacje
Lokalizacje studiów
-
-
New Jersey
-
Hackensack, New Jersey, Stany Zjednoczone, 07601
- Hackensack University Medical Center - Pulmonary Rehabilitation
-
-
Kryteria uczestnictwa
Kryteria kwalifikacji
Wiek uprawniający do nauki
Akceptuje zdrowych ochotników
Płeć kwalifikująca się do nauki
Metoda próbkowania
Badana populacja
Opis
Inclusion Criteria:
- COPD
- rehabilitation program
- FEV1<60%
Exclusion Criteria:
- FEV1>60%
Plan studiów
Jak projektuje się badanie?
Szczegóły projektu
Współpracownicy i badacze
Sponsor
Śledczy
- Główny śledczy: Hormoz Ashtyani, MD, Hackensack Meridian Health
- Główny śledczy: Susan Zafarlotfi, Ph.D, Hackensack Meridian Health
Daty zapisu na studia
Główne daty studiów
Rozpoczęcie studiów
Zakończenie podstawowe (Rzeczywisty)
Ukończenie studiów (Rzeczywisty)
Daty rejestracji na studia
Pierwszy przesłany
Pierwszy przesłany, który spełnia kryteria kontroli jakości
Pierwszy wysłany (Oszacować)
Aktualizacje rekordów badań
Ostatnia wysłana aktualizacja (Oszacować)
Ostatnia przesłana aktualizacja, która spełniała kryteria kontroli jakości
Ostatnia weryfikacja
Więcej informacji
Terminy związane z tym badaniem
Słowa kluczowe
Dodatkowe istotne warunki MeSH
Inne numery identyfikacyjne badania
- 06.01.008
Te informacje zostały pobrane bezpośrednio ze strony internetowej clinicaltrials.gov bez żadnych zmian. Jeśli chcesz zmienić, usunąć lub zaktualizować dane swojego badania, skontaktuj się z register@clinicaltrials.gov. Gdy tylko zmiana zostanie wprowadzona na stronie clinicaltrials.gov, zostanie ona automatycznie zaktualizowana również na naszej stronie internetowej .
Badania kliniczne na POChP
-
University Hospital, MahdiaNieznanyOstre zaostrzenie CopdTunezja
-
Centre Hospitalier Universitaire, AmiensZakończonyOstre zaostrzenie CopdFrancja
-
Huashan HospitalNieznanyŻylna choroba zakrzepowo-zatorowa | Ostre zaostrzenie CopdChiny
-
National Taiwan University HospitalZakończony
-
Prince of Songkla UniversityZakończonyRozstrzenie oskrzeli | Zmniejszona czynność płuc | Zaostrzenie CopdTajlandia
-
Erasmus Medical CenterZonMw: The Netherlands Organisation for Health Research and DevelopmentRekrutacyjnyPOChP | Zaostrzenie POChP | Ostre zaostrzenie CopdHolandia
-
Shanghai Asclepius Meditec Inc.Shanghai Zhongshan Hospital; Shanghai 10th People's Hospital; The First Affiliated... i inni współpracownicyZakończony
-
Joon Young ChoiSeoul St. Mary's Hospital; Hallym University Medical Center; Konkuk University...ZakończonyPOChP | Zaostrzenie CopdRepublika Korei
-
University Hospital, LinkoepingLinkoeping University; PEAS InstitutZakończonyZapalenie płuc | Pozaszpitalne zapalenie płuc | Zaostrzenie CopdSzwecja